Skip to main content
High RiskFDAfda-F-2004-2016SALMONELLA CONTAMINATION

The Republic of Tea - Organic Turmeric Ginger: Green Tea Ingredients: Organic Turmeric, Organic Green Tea, Organic Ginger, Organic Cinna...

Category
Units Affected
250
Recall Date
April 29, 2016
Issuing Agency
Hazard
Salmonella Contamination

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2004-2016.

Republic of Tea was notified by their supplier of a positive result for Salmonella in organic ginger that they received and distributed.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2004-2016.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Republic Of Tea or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2004-2016.

Republic Of Tea

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Republic Of Tea Recall FAQ

Republic Of Tea is the subject of a beverages safety report: The Republic of Tea - Organic Turmeric Ginger: Green Tea Ingredients: Organic Turmeric, Organic Green Tea, Organic Ginger, Organic Cinna.... The notice was published on April 29, 2016 by the U.S. Food and Drug Administration (FDA). Approximately 250 units are potentially affected.